abil
infecti
bronchiti
massachusett
strain
strain
live
attenu
vaccin
virus
protect
two
middl
east
infecti
bronchiti
viru
isol
broiler
chick
investig
dayold
chick
separ
three
group
vaccin
dayold
follow
daysold
ii
vaccin
simultan
dayold
daysold
iii
control
unvaccin
daysold
group
challeng
virul
protect
evalu
base
clinic
sign
tracheal
kidney
gross
lesion
tracheal
ciliostasi
result
show
administ
combin
live
vaccin
simultan
dayold
follow
vaccin
daysold
gave
per
cent
tracheal
ciliari
protect
middl
east
isol
addit
programm
confer
per
cent
protect
clinic
sign
tracheal
kidney
lesion
vaccin
programm
dayold
follow
daysold
tracheal
ciliari
protect
confer
per
cent
per
cent
respect
awad
f
et
al
vet
rec
open
infecti
bronchiti
viru
ibv
ubiquit
viru
high
mutat
larg
number
serotyp
genotyp
ibv
strain
report
worldwid
de
wit
other
variant
strain
emerg
due
chang
ibv
genom
point
mutat
delet
insert
rna
recombin
variant
often
respons
ib
outbreak
vaccin
chicken
flock
cavanagh
other
high
similar
strain
ibv
report
throughout
middl
east
north
africa
meir
other
iraq
mahmood
other
egypt
abdelmoneim
other
turkey
kahya
other
libya
awad
other
case
sever
respiratori
distress
renal
lesion
high
mortal
observ
vaccin
flock
affect
strain
appear
convent
vaccin
alon
provid
suffici
protect
strain
meir
other
kahya
other
howev
develop
vaccin
new
variant
gener
option
due
high
cost
time
requir
product
registr
jackwood
other
bijlenga
other
furthermor
could
neverend
race
new
variant
ibv
constantli
emerg
major
poultri
produc
countri
instead
recommend
protect
confer
avail
live
ibv
vaccin
new
variant
constantli
evalu
alvarado
other
vaccin
one
serotyp
ensur
complet
protect
heterolog
strain
cook
other
use
differ
combin
live
ibv
vaccin
shown
abl
induc
high
broad
protect
challeng
sever
heterolog
virul
ibv
variant
gelb
other
cook
other
cook
other
alvarado
other
martin
other
terregino
other
object
studi
evalu
protect
confer
avail
live
ibv
vaccin
use
strateg
manner
two
promin
middl
east
variant
ibv
relat
meir
other
genbank
acces
number
addit
convent
vaccin
programm
mass
dayold
follow
variant
daysold
author
also
evalu
anoth
vaccin
programm
mass
variant
live
vaccin
given
simultan
dayold
follow
variant
vaccin
daysold
follow
challeng
protect
assess
base
ciliostasi
assay
recommend
european
pharmacopoeia
europ
addit
clinic
sign
gross
lesion
evalu
dayold
commerci
broiler
chick
ibv
matern
deriv
antibodi
mda
obtain
commerci
hatcheri
parent
flock
chick
vaccin
live
ibv
vaccin
inactiv
ibv
chick
kept
isol
unit
univers
liverpool
chick
rear
deep
litter
water
feed
provid
ad
libitum
two
differ
commerci
live
vaccin
use
studi
vaccin
belong
massachusett
serotyp
merial
sa
lyon
franc
ii
vaccin
belong
serotyp
merial
sa
lyon
franc
vaccin
kept
use
vaccin
dissolv
steril
distil
water
ibv
challeng
strain
virul
strain
ibv
refer
refer
use
challeng
virus
virus
isol
recent
outbreak
high
mortal
respiratori
diseas
broiler
flock
egypt
isol
submit
istituto
zooprofilattico
sperimental
dell
venezi
padova
itali
third
passag
allanto
fluid
laboratori
allanto
fluid
screen
avian
influenza
viru
newcastl
diseas
viru
ibv
neg
avian
influenza
viru
newcastl
diseas
viru
posit
ibv
univers
liverpool
strain
identifi
revers
transcriptasepcr
sequenc
analysi
show
per
cent
nucleotid
level
ident
isra
strain
meir
other
base
analysi
strain
show
per
cent
nucleotid
level
ident
israel
strain
pairwis
comparison
gene
sequenc
show
low
level
ident
mass
type
awad
other
titr
isol
determin
specif
pathogenfre
embryon
chicken
egg
express
per
cent
egg
infecti
dose
eid
follow
method
reed
muench
reed
muench
nineti
oneday
old
commerci
broiler
chick
divid
three
group
chick
hous
differ
isol
room
one
day
age
group
inocul
vaccin
group
ii
inocul
combin
vaccin
day
age
bird
group
ii
revaccin
vaccin
group
iii
shaminocul
day
old
chick
inocul
via
oculo
nasal
rout
dosag
given
recommend
manufactur
follow
vaccin
bird
observ
daili
clinic
sign
blood
collect
prior
vaccin
day
day
old
eight
chick
group
antibodi
respons
day
chick
group
vaccin
control
group
transfer
anoth
isol
room
challeng
oculonas
rout
ml
virul
provid
eid
chick
anoth
chick
group
similarli
transfer
challeng
ml
virul
provid
eid
chick
remain
chick
vaccin
unvaccin
control
group
left
unchalleng
control
bird
observ
daili
clinic
sign
postchalleng
period
five
day
challeng
ten
chick
unchalleng
challeng
group
human
euthanas
wing
vein
inject
ml
euthen
pentobarbiton
sodium
rhone
merrieux
ireland
vaccin
protect
evalu
ciliostasi
test
examin
trachea
kidney
gross
lesion
sera
collect
prior
vaccin
day
old
test
use
commerci
elisa
biochek
gouda
netherland
follow
protocol
recommend
manufactur
haemagglutin
inhibit
hi
test
carri
describ
alexand
chettl
ibv
antigen
use
hi
assay
purchas
anim
health
servic
devent
netherland
haemagglutinin
antigen
prepar
author
laboratori
base
method
describ
alexand
chettl
king
hopkin
assess
protect
challeng
virus
carri
describ
other
cook
other
five
day
challeng
bird
human
kill
section
trachea
immedi
larynx
thorac
inlet
care
dissect
place
warm
tracheal
organ
cultur
medium
eagl
serumfre
minimum
essenti
medium
glutamin
streptomycin
mgml
penicillin
iuml
trachea
cut
use
tissu
chopper
mickl
laboratori
engin
give
thick
ring
ring
three
top
bottom
four
middl
trachea
examin
ciliari
activ
use
lowpow
microscop
magnif
ring
ciliari
activ
score
cilia
beat
per
cent
beat
per
cent
beat
per
cent
beat
none
beat
per
cent
ciliostasi
bird
ring
examin
maximum
possibl
ciliari
score
indic
total
lack
protect
cilia
beat
ring
mean
ciliari
score
bird
calcul
percentag
protect
group
use
formula
describ
other
cook
other
mean
ciliostasi
score
vaccinatedchalleng
group
mean
ciliostasi
score
correspond
challeng
control
chick
euthanas
five
day
post
challeng
dpc
also
examin
individu
gross
tracheal
kidney
lesion
score
accordingli
use
fourpoint
scale
trachea
lesion
exud
trachea
bronchi
exud
plug
trachea
bronchi
air
saccul
perihepat
pericard
ii
kidney
lesion
pale
visibl
urat
swell
pale
tubul
uret
distend
urat
total
gross
lesion
score
group
calcul
base
mean
score
observ
per
total
number
chick
elisa
hi
antibodi
titr
gross
lesion
group
analys
statist
use
analysi
varianc
follow
tukey
test
comparison
mean
differ
consid
signific
analys
conduct
use
graphpad
prism
softwar
clinic
sign
found
unvaccin
control
chick
vaccin
group
mild
clinic
respiratori
sign
began
appear
six
day
post
vaccin
dpv
sign
includ
head
shake
tracheal
sneez
sign
subsid
dpv
mean
elisa
antibodi
titr
prior
vaccin
dayold
mda
mean
ibv
hi
titr
ibv
prior
vaccin
dayold
mda
log
log
log
log
respect
day
age
day
challeng
vaccin
group
show
significantli
higher
level
ibv
elisa
antibodi
titr
unvaccin
control
group
chick
group
ii
exhibit
significantli
higher
antibodi
titr
p
group
fig
hi
respons
higher
heterolog
antigen
fig
use
antigen
vaccin
chicken
show
high
level
hi
antibodi
titr
compar
control
group
group
iii
antibodi
titr
antigen
group
ii
significantli
higher
group
fig
unvaccin
vaccinatedunchalleng
group
remain
free
clinic
sign
chick
unvaccinatedchalleng
chick
show
sign
typic
ibv
infect
dpc
includ
depress
ruffl
feather
listless
huddl
head
shake
tracheal
sneez
cough
sign
continu
dpc
contrast
clinic
sign
observ
vaccinatedchalleng
group
percentag
ciliari
protect
calcul
group
unvaccin
vaccinatedunchalleng
group
greater
per
cent
protect
unvaccin
group
iii
bird
challeng
either
virus
per
cent
protect
tabl
group
ii
group
show
per
cent
per
cent
ciliari
protect
challeng
respect
tabl
follow
challeng
group
group
ii
gave
per
cent
per
cent
protect
respect
tabl
unvaccin
vaccinatedunchalleng
control
group
remain
free
gross
lesion
five
day
challeng
congest
trachea
pale
swollen
kidney
observ
chick
group
iii
unvaccinatedchalleng
significantli
differ
vaccin
group
lesion
also
found
group
tabl
howev
signific
differ
observ
group
group
iii
regard
kidney
lesion
bird
group
ii
free
gross
lesion
follow
challeng
congest
trachea
pale
swollen
kidney
observ
one
bird
group
appear
normal
rest
bird
tabl
chick
group
ii
show
tracheal
kidney
lesion
howev
signific
differ
observ
two
vaccin
group
evalu
protect
confer
live
vaccin
virul
isol
assess
base
ciliari
activ
tracheal
explant
prepar
vaccinatedchalleng
chick
darbyshir
andrad
other
marquardt
other
snyder
other
cook
other
gross
lesion
trachea
kidney
follow
challeng
respect
virus
studi
similar
experiment
work
martin
other
terregino
other
field
practic
live
vaccin
reconstitut
appli
chick
dosag
recommend
vaccin
manufactur
combin
vaccin
programm
live
vaccin
simultan
given
one
dayold
follow
vaccin
two
week
later
group
ii
provid
excel
protect
isol
follow
challeng
clinic
sign
trachealkidney
lesion
ciliari
protect
high
per
cent
group
live
vaccin
alon
dayold
follow
vaccin
two
week
later
show
per
cent
per
cent
protect
respect
appear
protect
confer
much
improv
given
togeth
group
ii
dayold
contrast
given
alon
group
must
note
vaccin
programm
given
group
ii
also
offer
per
cent
kidney
protect
isol
previou
studi
perform
specif
pathogenfre
chick
live
vaccin
afford
protect
trachea
per
cent
kidney
per
cent
basi
viru
isol
bird
challeng
meir
other
moreov
immunis
live
given
singli
report
produc
littl
crossprotect
challeng
nephropathogen
ibv
strain
albassam
other
lambrecht
other
pensaert
lambrecht
present
studi
show
vaccin
programm
group
ii
boost
ciliari
tracheal
kidney
protect
compar
group
vaccin
programm
use
experi
provid
excel
protect
virul
challeng
better
protect
observ
group
ii
fig
mean
elisa
antibodi
titr
day
age
group
group
group
iiicontrol
bar
repres
eight
bird
group
differ
superscript
lowercas
letter
bar
indic
signific
differ
p
data
letter
indic
signific
differ
p
cutoff
fig
haemagglutin
inhibit
hi
antibodi
titr
log
infecti
bronchiti
viru
ibv
antigen
day
age
group
group
group
iii
control
bar
repres
eight
bird
group
differ
superscript
letter
bar
indic
signific
differ
p
data
letter
indic
signific
differ
p
within
antigen
cutoff
compar
group
could
due
higher
level
local
cellular
immun
tracheal
site
may
prevent
virul
viru
reach
kidney
lambrecht
other
anoth
experi
cellular
local
immun
induc
administr
combin
live
massachusett
vaccin
dayold
show
signific
increas
express
igabear
b
cell
trachea
compar
singl
alon
unvaccin
group
awad
ganapathi
unpublish
result
reinforc
import
optimis
local
cellmedi
mucos
immun
respiratori
line
strateg
heterolog
dayold
vaccin
enhanc
protect
variant
virus
humor
antibodi
respons
follow
vaccin
measur
elisa
hi
often
use
monitor
vaccinetak
raj
jone
studi
day
age
challeng
day
mean
elisa
titr
mean
hi
titr
group
ii
significantli
higher
vaccin
group
reflect
combin
live
ibv
vaccin
dayold
revaccin
daysold
provid
immunolog
boost
compar
vaccin
schedul
group
although
demonstr
circul
humor
antibodi
level
minor
import
protect
ibv
infect
raggi
lee
darbyshir
peter
endomunoz
faragh
pensaert
lambrecht
present
studi
group
higher
level
humor
antibodi
better
protect
middl
east
isol
cytotox
cell
play
vital
antivir
activ
earli
stage
ibv
infect
serum
igg
critic
late
stage
ibv
infect
collisson
other
despit
low
level
genet
ident
protein
vaccin
challeng
strain
use
studi
protect
achiev
vaccin
programm
employ
present
studi
high
genet
relationship
hypervari
region
gene
per
cent
per
cent
respect
genet
relationship
per
cent
per
cent
respect
awad
other
despit
per
cent
variat
gene
success
protect
confer
vaccin
programm
employ
studi
may
attribut
share
characterist
protein
vaccin
challeng
ibv
cavanagh
other
base
data
present
studi
appear
combin
live
vaccin
given
dayold
follow
vaccin
day
age
confer
excel
protect
virul
variant
virus
work
need
establish
underli
immun
mechan
higher
broader
protect
confer
vaccin
programm
b
ii
iii
b
b
b
b
group
group
group
iiiunvaccin
control
sever
gross
lesion
induc
virul
ibv
infect
data
express
median
minimummaximum
number
per
group
differ
superscript
lowercas
letter
within
column
indic
signific
differ
p
data
letter
indic
signific
differ
p
mean
score
vaccin
challeng
groupmean
score
challeng
control
group
higher
score
better
protect
